Biologic and Clinical Aspects of Rhabdomyosarcoma

Arya Emami ¹, Zahra Sepehri ², Joseph W. Gordon ^3,4,5, Saeid Ghavami ^5,6 *

Cited by CrossRef: 3

1- Moghadam A, da Silva Rosa S, Samiei E, Alizadeh J, Field J, Kawalec P, Thliveris J, Akbari M, Ghavami S, Gordon J. Autophagy modulates temozolomide-induced cell death in alveolar Rhabdomyosarcoma cells. Cell Death Discov. 2018;4(1) [Crossref]

2- Satală C, Jung I, Bara T, Simu P, Simu I, Vlad M, Szodorai R, Gurzu S. Primary rhabdomyosarcoma: An extremely rare and aggressive variant of male breast cancer. WJCC. 2020;8(19):4466 [Crossref]

3- Kilic-Kurt Z, Bakar-Ates F, Bahat M. N,N′-diaryl urea derivatives: Molecular docking, molecular properties prediction and anticancer evaluation. Journal of Molecular Structure. 2019;1193:239 [Crossref]

4- Panferova A, Sinichenkova K, Abu Jabal M, Usman N, Sharlai A, Roshchin V, Konovalov D, Druy A. Case report: EWSR1-TFCP2 in an adolescent represents an extremely rare and aggressive form of intraosseous spindle cell rhabdomyosarcomas. Cold Spring Harb Mol Case Stud. 2022;8(5):a006209 [Crossref]

5- Zhan X, Liu Y, Jannu A, Huang S, Ye B, Wei W, Pandya P, Ye X, Pollok K, Renbarger J, Huang K, Zhang J. Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining. Front Oncol. 2023;13 [Crossref]

Indexing Info:

Member of: